Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Schweizerische Medizinische Wochenschrift|October 9, 1999
[Is there progress in the chemotherapy of small cell lung cancer?]A Calderoni, T Cerny, D C Betticher
British Medical Bulletin|July 1, 1995
Melanoma: chemotherapyS M Lee, D C Betticher, N Thatcher
Schweizerische Medizinische Wochenschrift|April 20, 1991
[Aplastic anemia in carbamazepine therapy]D C Betticher, H P Wolfisberg, R Krapf
Schweizerische Medizinische Wochenschrift|March 18, 1995
[Diagnosis and therapy of multiple myeloma: current aspects]D C Betticher, T Cerny, M F Fey
Anti-Cancer Drugs|December 1, 1995
Symptomatic benefit from gemcitabine and other chemotherapy in advanced non-small cell lung cancer: changes in performance status and tumour-related symptomsN Thatcher, H Anderson, D C Betticher, et al.
Therapeutische Umschau. Revue Therapeutique|August 14, 1998
[Curative radiotherapy in locally advanced non-small-cell bronchial carcinoma (NSCLC)]C von Briel, D C Betticher, H B Ris
Cell Death and Differentiation|August 16, 2002
Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathwayF Pirnia, E Schneider, D C Betticher, et al.
British Journal of Cancer|January 1, 1997
Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patientsD C Betticher, J Heighway, N Thatcher, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Pharmacokinetics of 2-chloro-2'-deoxyadenosine administered subcutaneously or by continuous intravenous infusionT Sonderegger, D C Betticher, T Cerny, et al.
Cancer Genetics and Cytogenetics|November 14, 1997
Myelodysplastic syndrome with biclonal monosomy 7 and trisomy 8 after treatment with cladribine (2-chloro-2-deoxyadenosine) and involved field radiation therapyF M Laurencet, G B Zulian, C Cabrol, et al.
Pageof 10